Clinical Pharmacology · Sedatives and Anxiolytics
Barbiturates
On this page 6 sections
In 30 seconds
Barbiturates are older sedatives that boost GABA-A receptor activity, producing effects from mild calm to general anesthesia to fatal respiratory arrest. Their narrow therapeutic index — the small gap between an effective dose and a lethal one — is why benzodiazepines replaced them for anxiety and insomnia. They survive today mainly for seizure control, anesthesia induction, refractory intracranial pressure, and some alcohol-withdrawal protocols. No reversal agent exists for overdose.
The college version
Mechanism
Barbiturates act on the same GABA-A receptor-chloride channel complex as benzodiazepines, but more dangerously. Benzodiazepines only increase how often the channel opens, and need GABA present to do it. Barbiturates increase how long the channel stays open once GABA binds, and at higher concentrations can open the channel directly, with no GABA required. This removes the natural ceiling on inhibition, letting CNS depression progress from sedation to coma to respiratory failure, since these receptors sit on the brainstem's respiratory centers — the basis of the narrow therapeutic index.
Classification and Naming
Barbiturate names share the suffix "-barbital" (phenobarbital, pentobarbital, butabarbital). They are grouped by duration:
- Ultra-short-acting: thiopental and methohexital, given IV to induce general anesthesia due to rapid onset and brief duration.
- Short/intermediate-acting: pentobarbital and butabarbital, historically used for sedation and insomnia.
- Long-acting: phenobarbital and primidone (converted to phenobarbital in the body), used for seizures due to slow onset and long duration.
Clinical Roles Today
Benzodiazepines and nonbenzodiazepine hypnotics displaced barbiturates from routine anxiety and sleep care due to their wider safety margin. Barbiturates persist where specific properties matter: phenobarbital for certain seizures including neonatal seizures; ultra-short agents for rapid anesthesia induction; high-dose barbiturate coma for refractory intracranial hypertension, suppressing cerebral metabolic demand; and phenobarbital in some alcohol-withdrawal protocols.
Enzyme Induction and Interactions
Barbiturates potently induce hepatic cytochrome P450 enzymes, speeding metabolism of co-administered drugs such as oral contraceptives, warfarin, and other anticonvulsants — risking therapeutic failure of those drugs whenever a barbiturate is started, adjusted, or stopped.
Tolerance, Dependence, and Withdrawal
Chronic use causes tolerance, requiring escalating doses without a matching gain in safety margin. Physical dependence develops, and abrupt discontinuation can trigger withdrawal — anxiety, tremor, seizures — potentially more dangerous than benzodiazepine withdrawal. No specific antidote exists for overdose; treatment is supportive: airway protection, ventilation, and hemodynamic stabilization until the drug clears.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Picture a light switch on a dimmer. Normally a helper (GABA) has to flip the switch before the dimmer works at all. Benzodiazepines just make the helper flip the switch more often. Barbiturates are sneakier: they make the light stay on-and-dim longer each time, and enough of the drug can turn the dimmer on by itself, no helper needed. That is why barbiturates can push someone from sleepy all the way to "breathing stops" — there's no built-in limit like with the safer medicines. Doctors still use small, careful amounts for seizures or surgery sleep, but switched to safer dimmer-only medicines for everyday anxiety or insomnia.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient stabilized on phenobarbital for seizures starts an oral contraceptive. What pharmacologic property of phenobarbital matters here, and why?
Show answer
Phenobarbital induces liver enzymes that break down other drugs faster, including oral contraceptives, making the contraceptive less reliable.
Think of the liver as a recycling machine that phenobarbital revs up — it chews through other medicines faster, so the contraceptive may not stay strong enough to work.
A patient on long-term high-dose barbiturates abruptly stops. What should the care team anticipate, and how does its urgency compare to benzodiazepine withdrawal?
Show answer
The team should expect withdrawal with anxiety, tremor, and seizures, treated as at least as urgent as, potentially more dangerous than, benzodiazepine withdrawal.
Stopping suddenly after the brain adjusts to constant barbiturate exposure can trigger seizures, so this is a medical emergency needing gradual, careful management, not abrupt cessation.
Quick check
3 questions here. Answers stay hidden until you check.
Which barbiturate is ultra-short-acting and used for anesthesia induction?
Why have benzodiazepines largely replaced barbiturates for anxiety and insomnia?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

